Literature DB >> 32246433

Quality of life in people with epidermolysis bullosa: a systematic review.

C C G Togo1, A P C Zidorio2, V S S Gonçalves3, L Hubbard4, K M B de Carvalho5, E S Dutra5.   

Abstract

PURPOSE: Individuals with epidermolysis bullosa (EB) present with various clinical manifestations of different severities that affect quality of life (QoL). This systematic review synthesizes the current evidence about the QoL of individuals with EB.
METHODS: We included observational studies with people of all age groups, both sexes, and any EB type. Studies with qualitative methodology, chapters of books, meeting proceedings, and abstracts were excluded.
RESULTS: In this study, 12 articles comprising 745 individuals were included. More than half of the articles observed lower QoL in individuals with recessive dystrophic EB (RDEB) or junctional EB (JEB). Three articles indicated that EB affected QoL more in women than in men, and one article identified that children with EB suffered more than adults with the disease. Pain was frequently reported. Seven articles identified difficulty in sports, two identified a need for bathing assistance, and three identified eating difficulties. Additionally, participants reported that family relationships and friendships were affected, and they experienced feelings of anxiety and depression. Some of the instruments used evaluated QoL in general dermatologic conditions, and one was specific to EB.
CONCLUSION: QoL is more affected in people who have RDEB and JEB. Regarding sex and age, women and children need special care in their monitoring. It is necessary that guidelines on pain management be more disseminated and put into practice. Future studies should use standardized specific instruments to assess the QoL in EB individuals, while considering the particularities of the different age groups.

Entities:  

Keywords:  Epidermolysis bullosa; Quality of life; Questionnaires; Systematic review

Year:  2020        PMID: 32246433     DOI: 10.1007/s11136-020-02495-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  9 in total

1.  A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.

Authors:  Jodi Y So; Shivali Fulchand; Christine Y Wong; Shufeng Li; Jaron Nazaroff; Emily S Gorell; Mark P de Souza; Dedee F Murrell; Joyce M Teng; Albert S Chiou; Jean Y Tang
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

Review 2.  Oral Alterations in Heritable Epidermolysis Bullosa: A Clinical Study and Literature Review.

Authors:  Alessandro Polizzi; Simona Santonocito; Romeo Patini; Vincenzo Quinzi; Stefano Mummolo; Rosalia Leonardi; Alberto Bianchi; Gaetano Isola
Journal:  Biomed Res Int       Date:  2022-05-31       Impact factor: 3.246

3.  Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers.

Authors:  Fatemeh Chogani; Mohammad Mahdi Parvizi; Dedee F Murrell; Farhad Handjani
Journal:  Int J Womens Dermatol       Date:  2021-08-26

4.  Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Kathrin Dieter; Elke Niebergall-Roth; Silvia Fluhr; Cristina Daniele; Jasmina Esterlechner; Samar Sadeghi; Seda Ballikaya; Leoni Erdinger; Franziska Schauer; Stella Gewert; Martin Laimer; Johann W Bauer; Alain Hovnanian; Giovanna Zambruno; May El Hachem; Emmanuelle Bourrat; Maria Papanikolaou; Gabriela Petrof; Sophie Kitzmüller; Christen L Ebens; Markus H Frank; Natasha Y Frank; Christoph Ganss; Anna E Martinez; John A McGrath; Jakub Tolar; Mark A Kluth
Journal:  JCI Insight       Date:  2021-11-22

5.  Patients' and parents' experiences during wound care of epidermolysis bullosa from a dyadic perspective: a survey study.

Authors:  Petra J Mauritz; Marieke Bolling; José C Duipmans; Mariët Hagedoorn
Journal:  Orphanet J Rare Dis       Date:  2022-08-13       Impact factor: 4.303

6.  Transcultural Validation of a Spanish Version of the Quality of Life in Epidermolysis Bullosa Questionnaire.

Authors:  Alvaro Rafael Villar Hernández; Fernando Molero Alonso; Álvaro Jesús Aguado Marín; Manuel Posada de la Paz
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

7.  Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa.

Authors:  Christine Prodinger; Anja Diem; Katherina Ude-Schoder; Josefina Piñón-Hofbauer; Sophie Kitzmueller; Johann W Bauer; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-07-10       Impact factor: 4.123

8.  Identifying Epidermolysis Bullosa Patient Needs and Perceived Treatment Benefits: An Explorative Study Using the Patient Benefit Index.

Authors:  Nicholas H B Schräder; Eva W H Korte; José C Duipmans; Roy E Stewart; Maria C Bolling; André P Wolff
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

Review 9.  Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the Clinician.

Authors:  Jessica J Padniewski; Rob L Shaver; Brittney Schultz; David R Pearson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.